Register Now: Advances in Spectroscopy for Pharma and Biopharmaceutical Analysis Symposium
|Articles|August 9, 2021

U.S. Food and Drug Administration Issues NIR Guidance

On August 6, 2021, the U.S. Food and Drug Administration (FDA) released final guidance regarding near-infrared (NIR) analytical procedures. The guidance applies to new drug applications (NDAs), abbreviated new drug applications (ANDAs), and supplemental NDAs and ANDAs for small-molecule drugs. The FDA will address recommendations for NIR methods used in biologics under a future revision of the guidance.

The new guidance provides the agency’s recommendations for the development, validation, and use of NIR-based analytical procedures in evaluating a drug product’s identity, strength, quality, purity, and potency. The recommendations address the application of concepts described in FDA and International Council for Harmonization guidelines to NIR analytical procedures that use chemometric models. It also discusses submitting NIR documentation in applications.

The guidance does not discuss the development and validation of NIR analytical procedures or the setup, qualification, maintenance, or calibration of NIR instruments. The concepts of the guidance can be applied to other analytical technologies.


Related to this article

Optical and Electronic Instrument Components,  ©  ridwan -chronicles-stock.adobe.com
The updated and expanded 2026 edition of Spectroscopy's Instrument Components Terminology Guide defines the sources, detectors, optical and dispersive elements, sampling hardware, physical constants, and unit conversions used across UV-vis, NIR, IR, Raman, X-ray, and atomic spectroscopic instrumentation, with new terms reflecting component developments reported between 2022 and 2026.
Pittsburgh, Pennsylvania, USA. Beautiful Pittsburgh at twilight. | Image Credit: © checubus - stock.adobe.com
Organized by CPACT, the April 27 to 29 meeting at the Marriott Pittsburgh City Center will bring together scientists, engineers, and vendors across the process industries, with keynotes on PAT, Raman, and NIR applications and an abstract deadline of December 7, 2026.